Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.


Early systemic hemodynamic adjustments to antihypertensive therapy with the cardioselective beta inhibitor, atenolol, were investigated in 12 hospitalized men, mean age 52 years, with uncomplicated mild-to-moderate essential hypertension. Twice daily measurements of cardiac output (CO) by CO2 rebreathing, blood pressure by cuff, and heart rate were… (More)


6 Figures and Tables